Recently Placed

Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group

February 6, 2024
Director, Global HEOR Rare Disease Immunology reporting to Montserrat Vera-Llonch was filled for Ionis. This is a critical and significant role as the commercial function… Continue Reading →

Ionis VP Medical Affairs Successfully Placed by The Chase Group

September 21, 2021
Ionis Pharmaceuticals has a 30-year track record of perfecting and advancing RNA-targeted drug discovery and development and is now expanding its commercialization capabilities. That expansion… Continue Reading →
Copyright © 1993-2025 The Chase Group. All Rights Reserved.